Rationale for combining immunotherapy with chemotherapy.

Rationale for combining immunotherapy with chemotherapy.

Item
http://www.wikidata.org/entity/Q38389326
Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy.Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients.Is immunity in cancer the key to improving clinical outcome?: Report on the International Symposium on Immunotherapy, The Royal Society, London, UK, 12-13 May 2017.NF-kappaB: Two Sides of the Same Coin.Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients.Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.A bifunctional nanomodulator for boosting CpG-mediated cancer immunotherapy.B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.Present and future of cancer immunotherapy: A tumor microenvironmental perspective
P2860

Rationale for combining immunotherapy with chemotherapy.

Item
http://www.wikidata.org/entity/Q38389326
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Rationale for combining immunotherapy with chemotherapy.
@en
type
label
Rationale for combining immunotherapy with chemotherapy.
@en
prefLabel
Rationale for combining immunotherapy with chemotherapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Rationale for combining immunotherapy with chemotherapy.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921